Deelnemende ziekenhuizen

Gesloten voor inclusie

  • Bernhoven (I. Ludwig)
  • Gelderse Vallei (D. te Raa)

Officiƫle titel

First line treatment with venetoclax and ibrutinib induction followed by obinutuzumab intensification exclusively in CLL/SLL patients not in complete remission and/or with detectable bone marrow minimal residual disease (NEXT STEP trial)

Studiedocumenten

Klik HIER voor de afgeschermde studiedocumenten (alleen toegankelijk via netwerk Radboudumc).